| Assessment Status | Rapid Review Complete |
| Drug | Tegafur/Gimeracil/Oteracil |
| Brand | Teysuno® |
| Indication | For the treatment of advanced gastric cancer. |
| Assessment Process | |
| Rapid review commissioned | 27/02/2012 |
| Rapid review completed | 23/03/2012 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |